Contraception :: Young women unfamiliar with safety, effectiveness of IUD
The IUD might be one of the best-kept birth control secrets for young women, according to researchers at the University of Rochester Medical Center.
The IUD might be one of the best-kept birth control secrets for young women, according to researchers at the University of Rochester Medical Center.
Expression of two different proteins taken from primary tumor biopsies is highly associated with spread of breast cancer to nearby lymph nodes, according to researchers who say this protein profile could help identify at an early stage those patients whose disease is likely to metastasize.
Health Minister Lord Warner today confirmed that over 18,000 additional specialty training opportunities will be available in England in 2007 to accompany the introduction of the new specialty training structure under Modernising Medical Careers.
The largest-ever study of carotid stenting in high-surgical risk patients has shown that with proper education and training, community physicians are just as successful at using catheter-based techniques to unclog arteries supplying blood to the brain as are those who pioneered the procedure at major university medical centers.
The widely used breast cancer drug tamoxifen (Nolvadex?), which can become less effective over time, might retain its full strength indefinitely if used along with a second drug, according to new research in mice conducted by investigators from the National Cancer Institute (NCI), part of the National Institutes of Health, and their partners. The results appear in the December 11, 2006, issue of Cancer Cell.
In future, the prevention of venous thromboembolism (VTE) in thousands of patients after knee-replacement surgery may become much easier with a new agent in capsule form, called dabigatran etexilate.
A multicenter study on treating common ear infections in children with ear tubes adds to a growing body of evidence that favors antibiotic ear drops over antibiotics swallowed in pill or liquid form in such cases, a UT Southwestern Medical Center researcher reports.
SEER-Medicare analysis finds older men with early prostate cancer who were treated lived longer than those who were not treated. Study published in Dec. 13th issue of JAMA.
Recent findings of an observational study by researchers at the University of Pennsylvania School of Medicine suggest that men between 65-80 years of age who received treatment for early stage, localized prostate cancer lived significantly longer than men who did not receive treatment. The study will be published in the Dec. 13 issue of JAMA.
Majority of healthcare professionals surveyed agree that patients with prostate cancer should receive a licensed treatment wherever possible.